Get started
Author

Rachel P. Sikorski

Observed names: R Sikorski, R. P. Sikorski, Rachel Sikorski, Rachel P. Sikorski
Observed institutions: Amgen (United States), Memorial Sloan Kettering Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, National Cancer Institute, Stanford University
OpenAlex ID: A5039097920
Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer
2007 · David B. Solit, S. Percy Ivy, et al. · Clinical Cancer Research · 212
The Benzo[c]phenanthridine Alkaloid, Sanguinarine, Is a Selective, Cell-active Inhibitor of Mitogen-activated Protein Kinase Phosphatase-1
2005 · Andreas Vogt, Aletheia Tamewitz, et al. · Journal of Biological Chemistry · 183
A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells
2008 · Andreas Vogt, Peter R. McDonald, et al. · Molecular Cancer Therapeutics · 77
Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
2010 · B Huang, R Sikorski, et al. · Gene Therapy · 75
PDF
Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
2011 · Baocheng Huang, Rachel Sikorski, et al. · Journal of Immunotherapy · 61
A Phase I Study of 17-Allylamino-17-Demethoxygeldanamycin Combined with Paclitaxel in Patients with Advanced Solid Malignancies
2008 · Suresh S. Ramalingam, Merrill J. Egorin, et al. · Clinical Cancer Research · 61
A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
2008 · Archie N. Tse, David S. Klimstra, et al. · Clinical Cancer Research · 59
PDF
Synthesis and biological evaluation of (−)-dictyostatin and stereoisomers
2007 · Youseung Shin, Jean-Hugues Fournier, et al. · Tetrahedron · 57
Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy
2010 · Stephen H Thorne, Wenchun Liang, et al. · Molecular Therapy · 51
PDF
Total Synthesis and Biological Evaluation of C16 Analogs of (−)-Dictyostatin
2007 · Won-Hyuk Jung, Cristian Harrison, et al. · Journal of Medicinal Chemistry · 50
Cell-Based and Biochemical Structure-Activity Analyses of Analogs of the Microtubule Stabilizer Dictyostatin
2007 · Brianne S. Raccor, Andreas Vogt, et al. · Molecular Pharmacology · 37
Alternate Mechanisms of Initial Pattern Recognition Drive Differential Immune Responses to Related Poxviruses
2010 · William E. O'Gorman, Padma Sampath, et al. · Cell Host & Microbe · 32
PDF
Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
2010 · Christopher H. Contag, Rachel Sikorski, et al. · Cancer Research · 26
Cellular Analysis of Disorazole C1and Structure–Activity Relationship of Analogs of the Natural Product
2005 · Peter Wipf, Thomas H. Graham, et al. · Chemical Biology & Drug Design · 26
Phase I and pharmacokinetic (PK) study of 17-allylamino-17 demethoxygeldanamycin (17-AAG) in combination with weekly paclitaxel for advanced solid malignancies
2007 · L. A. Musquire, S. Ramalingam, et al. · Journal of Clinical Oncology · 2
Supplementary Data from A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
2023 · Archie N. Tse, David S. Klimstra, et al.
Data from A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
2023 · Archie N. Tse, David S. Klimstra, et al.
Data from A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
2023 · Archie N. Tse, David S. Klimstra, et al.
Supplementary Data from A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
2023 · Archie N. Tse, David S. Klimstra, et al.
PDF
Supplementary Figures 1-3 from Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
2023 · Christopher H. Contag, Rachel Sikorski, et al.
PDF
Supplementary Figures 1-3 from Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
2023 · Christopher H. Contag, Rachel Sikorski, et al.
Data from Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
2023 · Christopher H. Contag, Rachel Sikorski, et al.
Data from Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
2023 · Christopher H. Contag, Rachel Sikorski, et al.
Splenectomy Restores Tumoricidal Activity of CD8+ T cells and Macrophages in Ocular Tumors
2012 · Kyle C. McKenna, Kelly M. Beatty, et al. · Investigative Ophthalmology & Visual Science
Works count: 25
Citation count: 1,010
H-index: 14
I10-index: 14
Year
Topic
Type